國立高雄大學圖資館 |

Language: English

Back

Preclinical drug development

Rogge, Mark C.

Preclinical drug development

Record Type:	Electronic resources : Monograph/item
Title/Author:	Preclinical drug developmentedited by Mark C. Rogge, David R. Taft.
other author:	Rogge, Mark C.
Published:	New York :Informa Healthcare,c2010.
Description:	1 online resource (viii, 359 p., [8] p. of plates) :ill. (some col.) ;27 cm.
Subject:	Drug development.
Online resource:	Connect to Informa resource
ISBN:	9781420084733 (electronic bk.)

Preclinical drug development
Preclinical drug development[electronic resource] /edited by Mark C. Rogge, David R. Taft. - 2nd ed. - New York :Informa Healthcare,c2010. - 1 online resource (viii, 359 p., [8] p. of plates) :ill. (some col.) ;27 cm. - Drugs and the pharmaceutical sciences ;187. - Drugs and the pharmaceutical sciences ;v. 161..

Includes bibliographical references and index.

The scope of preclinical drug development : an introduction and framework / Mark C. Rogge -- Lead molecule selection : pharmaceutical profiling and toxicity assessments / P.L. Bullock -- Interspecies differences in physiology and pharmacology : extrapolating preclinical data to human populations / M.N. Martinez -- Pharmacokinetics/ADME of small molecules / A.D. Ajavon and David R. Taft -- Pharmacokinetics/ADME of large molecules / R. Braeckman -- Preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development / P.L. Bonate and P. Vicini -- Formulation and production strategies for enhancing bioavailability of poorly absorbed drugs / A.B. Watts and R.O. Williams III -- Transporters involved in drug disposition, toxicity, and efficacy / C.Q. Xia and G.T. Miwa -- Toxicity evaluations, ICH guidelines, and current practice / J.L. Larson -- Application of pathology in safety assessment / Robert A. Ettlin and David E. Prentice -- Utilizing the preclinical database to support clinical drug development / H. Lee.

ISBN: 9781420084733 (electronic bk.)

LCCN: 2009025807

Nat. Bib. No.: GBA967536bnb

Nat. Bib. Agency Control No.: 101508920DNLMSubjects--Topical Terms:

190608
Drug development.

LC Class. No.: RM301.25 / .P745 2010

Dewey Class. No.: 615/.19

National Library of Medicine Call No.: W1 / DR893B v.187 2010

Preclinical drug development
LDR:02360cmm a2200373 a 4500 001 310020
003 OCoLC
005 20111126222232.0
006 m d
007 cr cnu---unuuu
008 111213s2010 nyua sb 001 0 eng d
010 $a 2009025807
015 $a GBA967536 $2 bnb
016 7 $a 101508920 $2 DNLM
016 7 $a 015307927 $2 Uk
019 $a 212853256
020 $a 9781420084733 (electronic bk.)
020 $a 9781420084726 (hardcover : alk. paper)
020 $a 1420084720 (hardcover : alk. paper)
035 $a (OCoLC)416216136 $z (OCoLC)212853256
035 $a ocn416216136
040 $a DNLM/DLC $c DLC $d BTCTA $d BAKER $d YDXCP $d NLM $d C#P $d MUQ $d UKM $d IG#
042 $a pcc
050 0 0 $a RM301.25 $b .P745 2010
060 0 0 $a W1 $b DR893B v.187 2010
060 1 0 $a QV 771 $b P9227 2010
082 0 0 $a 615/.19 $2 22
245 0 0 $a Preclinical drug development $h [electronic resource] / $c edited by Mark C. Rogge, David R. Taft.
250 $a 2nd ed.
260 $a New York : $b Informa Healthcare, $c c2010.
300 $a 1 online resource (viii, 359 p., [8] p. of plates) : $b ill. (some col.) ; $c 27 cm.
490 1 $a Drugs and the pharmaceutical sciences ; $v 187
504 $a Includes bibliographical references and index.
505 0 $a The scope of preclinical drug development : an introduction and framework / Mark C. Rogge -- Lead molecule selection : pharmaceutical profiling and toxicity assessments / P.L. Bullock -- Interspecies differences in physiology and pharmacology : extrapolating preclinical data to human populations / M.N. Martinez -- Pharmacokinetics/ADME of small molecules / A.D. Ajavon and David R. Taft -- Pharmacokinetics/ADME of large molecules / R. Braeckman -- Preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development / P.L. Bonate and P. Vicini -- Formulation and production strategies for enhancing bioavailability of poorly absorbed drugs / A.B. Watts and R.O. Williams III -- Transporters involved in drug disposition, toxicity, and efficacy / C.Q. Xia and G.T. Miwa -- Toxicity evaluations, ICH guidelines, and current practice / J.L. Larson -- Application of pathology in safety assessment / Robert A. Ettlin and David E. Prentice -- Utilizing the preclinical database to support clinical drug development / H. Lee.
650 0 $a Drug development. $3 190608
650 6 $a Maedicaments $x Daeveloppement. $3 531491
650 1 2 $a Drug Evaluation, Preclinical $x methods. $3 252149
650 2 2 $a Drug Industry $x methods. $3 265448
700 1 $a Rogge, Mark C. $3 302698
700 1 $a Taft, David R. $3 302699
830 0 $a Drugs and the pharmaceutical sciences ; $v v. 161. $3 444099
856 4 $z Connect to Informa resource $u http://informahealthcare.com/action/showBook?doi=10.3109%2F9781420084733